Finding the Right Keys: Using Antibody Therapy to Fight Infectious Diseases




Scientists first identified antibodies as mediators of adaptive immunity in the early 20th century. With the development of hybridoma antibody technology in the 1970s, scientists harnessed the power of antibodies as selective therapeutic agents. Today, antibody therapies treat a plethora of ailments, from drug-resistant infections to emerging pathogens, such as SARS-CoV-2.

Download this infographic from Drug Discovery News to relive the history of antibody-based immunotherapy research and learn how scientists today use monoclonal antibody therapies to treat infectious diseases.

Supported by

ATCC - pup LOGO - 6b2506ed-efe0-480e-8beb-3f67d22c3d67}_ATCC_logo_Purple_400x373_Transparent       Bethyl-Logo